Display options
Share it on

Beilstein J Org Chem. 2014 Mar 04;10:544-98. doi: 10.3762/bjoc.10.50. eCollection 2014.

Isocyanide-based multicomponent reactions towards cyclic constrained peptidomimetics.

Beilstein journal of organic chemistry

Gijs Koopmanschap, Eelco Ruijter, Romano Va Orru

Affiliations

  1. Department of Chemistry & Pharmaceutical Sciences, Amsterdam Institute of Molecules, Medicines and Systems, VU University Amsterdam, de Boelelaan 1083, 1081 HV, Amsterdam, The Netherlands.

PMID: 24605172 PMCID: PMC3943360 DOI: 10.3762/bjoc.10.50

Abstract

In the recent past, the design and synthesis of peptide mimics (peptidomimetics) has received much attention. This because they have shown in many cases enhanced pharmacological properties over their natural peptide analogues. In particular, the incorporation of cyclic constructs into peptides is of high interest as they reduce the flexibility of the peptide enhancing often affinity for a certain receptor. Moreover, these cyclic mimics force the molecule into a well-defined secondary structure. Constraint structural and conformational features are often found in biological active peptides. For the synthesis of cyclic constrained peptidomimetics usually a sequence of multiple reactions has been applied, which makes it difficult to easily introduce structural diversity necessary for fine tuning the biological activity. A promising approach to tackle this problem is the use of multicomponent reactions (MCRs), because they can introduce both structural diversity and molecular complexity in only one step. Among the MCRs, the isocyanide-based multicomponent reactions (IMCRs) are most relevant for the synthesis of peptidomimetics because they provide peptide-like products. However, these IMCRs usually give linear products and in order to obtain cyclic constrained peptidomimetics, the acyclic products have to be cyclized via additional cyclization strategies. This is possible via incorporation of bifunctional substrates into the initial IMCR. Examples of such bifunctional groups are N-protected amino acids, convertible isocyanides or MCR-components that bear an additional alkene, alkyne or azide moiety and can be cyclized via either a deprotection-cyclization strategy, a ring-closing metathesis, a 1,3-dipolar cycloaddition or even via a sequence of multiple multicomponent reactions. The sequential IMCR-cyclization reactions can afford small cyclic peptide mimics (ranging from four- to seven-membered rings), medium-sized cyclic constructs or peptidic macrocycles (>12 membered rings). This review describes the developments since 2002 of IMCRs-cyclization strategies towards a wide variety of small cyclic mimics, medium sized cyclic constructs and macrocyclic peptidomimetics.

Keywords: heterocycles; isocyanides; macrocycles; medicinal chemistry; multicomponent reaction; organic synthesis; peptidomimetics

References

  1. Amino Acids. 2008 Jan;34(1):1-24 - PubMed
  2. J Org Chem. 2002 May 3;67(9):3057-64 - PubMed
  3. J Pept Sci. 2003 Aug;9(8):471-501 - PubMed
  4. Chem Rev. 2012 Jun 13;112(6):3083-135 - PubMed
  5. Org Lett. 2002 Apr 4;4(7):1167-70 - PubMed
  6. J Am Chem Soc. 2010 Mar 10;132(9):2889-91 - PubMed
  7. Annu Rev Cell Dev Biol. 1996;12:697-715 - PubMed
  8. Bioorg Med Chem Lett. 2004 Nov 15;14(22):5689-92 - PubMed
  9. Bioorg Med Chem Lett. 2006 Jul 1;16(13):3463-8 - PubMed
  10. Chemistry. 2011 Oct 24;17(44):12257-61 - PubMed
  11. Mol Divers. 2003;6(3-4):227-35 - PubMed
  12. Arch Pharm (Weinheim). 2001 May;334(5):167-72 - PubMed
  13. Chemistry. 2004 Jul 5;10(13):3286-300 - PubMed
  14. J Org Chem. 2008 Jan 18;73(2):719-22 - PubMed
  15. Science. 1980 Nov 7;210(4470):656-8 - PubMed
  16. J Am Chem Soc. 2002 Mar 20;124(11):2560-7 - PubMed
  17. J Org Chem. 2006 Oct 13;71(21):8244-9 - PubMed
  18. J Am Chem Soc. 2002 Nov 6;124(44):13097-105 - PubMed
  19. J Am Chem Soc. 2005 Jan 19;127(2):506-7 - PubMed
  20. J Med Chem. 2006 Oct 5;49(20):6133-7 - PubMed
  21. Mol Divers. 2010 Feb;14(1):59-65 - PubMed
  22. Org Biomol Chem. 2008 Sep 7;6(17):3158-65 - PubMed
  23. Bioorg Med Chem Lett. 2012 Apr 1;22(7):2598-603 - PubMed
  24. Chem Soc Rev. 2011 Aug;40(8):4295-306 - PubMed
  25. Org Biomol Chem. 2012 Feb 14;10(6):1255-74 - PubMed
  26. Org Lett. 2006 Aug 31;8(18):4145-8 - PubMed
  27. Org Lett. 2002 May 30;4(11):1967-9 - PubMed
  28. Biol Pharm Bull. 2000 May;23(5):654-6 - PubMed
  29. J Org Chem. 2008 Mar 7;73(5):1762-7 - PubMed
  30. Anticancer Drugs. 2006 Jan;17(1):25-31 - PubMed
  31. Org Lett. 2004 Dec 9;6(25):4771-4 - PubMed
  32. Chemistry. 2013 May 10;19(20):6417-28 - PubMed
  33. J Med Chem. 2003 Oct 9;46(21):4393-404 - PubMed
  34. Nat Prod Rep. 1997 Feb;14(1):75-82 - PubMed
  35. Org Lett. 2002 Feb 21;4(4):639-41 - PubMed
  36. Mol Pharm. 2012 Nov 5;9(11):2961-73 - PubMed
  37. J Med Chem. 2007 Nov 29;50(24):5890-3 - PubMed
  38. Bioorg Med Chem Lett. 2001 Apr 23;11(8):1065-8 - PubMed
  39. Bioorg Med Chem Lett. 2005 Aug 15;15(16):3732-6 - PubMed
  40. Curr Opin Chem Biol. 2002 Jun;6(3):306-13 - PubMed
  41. J Pept Res. 2005 Feb;65(2):229-60 - PubMed
  42. Org Biomol Chem. 2010 Feb 7;8(3):529-32 - PubMed
  43. J Am Chem Soc. 2001 Jul 11;123(27):6700-1 - PubMed
  44. Angew Chem Int Ed Engl. 2008;47(49):9454-7 - PubMed
  45. Pharmazie. 2001 Jan;56(1):18-22 - PubMed
  46. Drugs Today (Barc). 2004 Nov;40(11):901-12 - PubMed
  47. Chem Soc Rev. 2010 Apr;39(4):1325-37 - PubMed
  48. Peptides. 2008 Aug;29(8):1305-11 - PubMed
  49. Bioorg Med Chem Lett. 2007 Mar 1;17(5):1341-5 - PubMed
  50. Bioorg Med Chem Lett. 2005 Mar 1;15(5):1429-33 - PubMed
  51. Bioorg Med Chem Lett. 2005 Feb 1;15(3):765-70 - PubMed
  52. Chem Rev. 2009 Feb;109(2):796-814 - PubMed
  53. Drug Discov Today. 2003 Dec 15;8(24):1128-37 - PubMed
  54. Bioorg Med Chem Lett. 2000 Feb 7;10(3):257-60 - PubMed
  55. J Med Chem. 2004 Jul 29;47(16):4054-9 - PubMed
  56. Bioorg Med Chem Lett. 2007 Jun 15;17(12):3362-6 - PubMed
  57. Proc Natl Acad Sci U S A. 2011 Apr 26;108(17):6793-8 - PubMed
  58. J Nat Prod. 2003 Oct;66(10):1299-301 - PubMed
  59. Org Lett. 2009 Mar 5;11(5):1167-70 - PubMed
  60. Chem Soc Rev. 2007 Oct;36(10):1674-89 - PubMed
  61. Chem Rev. 2001 Dec;101(12):3893-4012 - PubMed
  62. Curr Opin Cell Biol. 2008 Oct;20(5):514-9 - PubMed
  63. Chem Rev. 2012 Jul 11;112(7):3641-716 - PubMed
  64. Org Lett. 2006 Nov 9;8(23):5369-72 - PubMed
  65. J Org Chem. 2007 Mar 16;72(6):2151-60 - PubMed
  66. Chem Soc Rev. 2012 May 21;41(10):3969-4009 - PubMed
  67. Chemistry. 2006 Sep 18;12(27):7178-89 - PubMed
  68. Chem Commun (Camb). 2010 Nov 14;46(42):7918-20 - PubMed
  69. Org Biomol Chem. 2006 Nov 21;4(22):4236-40 - PubMed
  70. J Am Chem Soc. 2006 Aug 2;128(30):9699-704 - PubMed
  71. J Org Chem. 2009 Mar 6;74(5):2189-92 - PubMed
  72. Beilstein J Org Chem. 2011;7:976-9 - PubMed
  73. J Org Chem. 2009 Sep 18;74(18):7084-93 - PubMed
  74. Acc Chem Res. 2001 Oct;34(10):826-35 - PubMed
  75. J Med Chem. 2008 Feb 28;51(4):988-96 - PubMed
  76. J Med Chem. 2007 Mar 22;50(6):1347-53 - PubMed
  77. Org Lett. 2004 Jan 8;6(1):39-42 - PubMed
  78. J Med Chem. 2005 Jun 16;48(12):3991-4008 - PubMed
  79. Mol Cancer Ther. 2006 Jan;5(1):160-9 - PubMed
  80. Chemistry. 2006 Jan 23;12(4):1174-84 - PubMed
  81. Curr Med Chem. 2005;12(5):589-97 - PubMed
  82. Curr Opin Pharmacol. 2006 Feb;6(1):18-23 - PubMed
  83. Eur J Med Chem. 2000 Jan;35(1):53-67 - PubMed
  84. Chemistry. 2013 Dec 23;19(52):17668-72 - PubMed
  85. J Org Chem. 2007 Dec 21;72(26):10239-42 - PubMed
  86. J Org Chem. 2010 Mar 5;75(5):1723-32 - PubMed
  87. Chem Commun (Camb). 2003 Mar 7;(5):596-7 - PubMed
  88. J Med Chem. 1995 Mar 3;38(5):771-93 - PubMed
  89. Angew Chem Int Ed Engl. 2010 Mar 15;49(12):2182-4 - PubMed
  90. J Med Chem. 1996 Apr 26;39(9):1898-906 - PubMed
  91. J Antibiot (Tokyo). 1986 Dec;39(12):1674-84 - PubMed
  92. J Org Chem. 2009 Jan 16;74(2):660-8 - PubMed
  93. J Nat Prod. 2007 Nov;70(11):1793-5 - PubMed
  94. Chem Commun (Camb). 2004 Sep 21;(18):2011-5 - PubMed
  95. Org Lett. 2003 Apr 3;5(7):1047-50 - PubMed
  96. Bioorg Med Chem. 2010 Oct 15;18(20):7193-202 - PubMed
  97. Mini Rev Med Chem. 2004 Jan;4(1):69-92 - PubMed
  98. Chem Biol Drug Des. 2010 Aug;76(2):116-29 - PubMed
  99. Nat Chem. 2011 Jun 23;3(7):509-24 - PubMed
  100. J Med Chem. 2004 Nov 4;47(23):5713-20 - PubMed
  101. J Antibiot (Tokyo). 2003 Feb;56(2):102-6 - PubMed
  102. J Med Chem. 2006 Jun 1;49(11):3064-7 - PubMed
  103. J Med Chem. 1991 May;34(5):1594-605 - PubMed
  104. J Agric Food Chem. 2005 Sep 7;53(18):7222-31 - PubMed
  105. Nature. 2005 Nov 10;438(7065):248-52 - PubMed
  106. Mol Divers. 2011 Feb;15(1):3-33 - PubMed
  107. Org Lett. 2008 Jan 17;10(2):205-8 - PubMed
  108. J Antibiot (Tokyo). 1987 Apr;40(4):455-8 - PubMed
  109. Curr Opin Chem Biol. 1998 Aug;2(4):441-52 - PubMed
  110. Bioorg Med Chem Lett. 2008 Apr 1;18(7):2385-9 - PubMed
  111. Org Lett. 2007 Nov 22;9(24):5035-8 - PubMed
  112. Angew Chem Int Ed Engl. 2011 Jul 4;50(28):6234-46 - PubMed
  113. J Mol Recognit. 1990 Apr;3(2):55-64 - PubMed
  114. Chem Commun (Camb). 2003 Oct 21;(20):2594-5 - PubMed
  115. J Med Chem. 1997 Aug 1;40(16):2502-24 - PubMed
  116. Bioorg Med Chem Lett. 2006 May 15;16(10):2748-52 - PubMed
  117. Bioorg Med Chem. 2002 Jun;10(6):1813-8 - PubMed
  118. Tetrahedron. 2012 Jul 8;68(27-28):5606-5611 - PubMed
  119. Angew Chem Int Ed Engl. 2010 Jul 19;49(31):5289-92 - PubMed
  120. Chem Rev. 2006 Jan;106(1):17-89 - PubMed
  121. Mol Divers. 2005;9(1-3):159-69 - PubMed
  122. J Am Chem Soc. 2004 Jan 21;126(2):444-5 - PubMed
  123. Chem Rev. 2010 Sep 8;110(9):5235-331 - PubMed
  124. Org Lett. 2000 Aug 24;2(17):2615-7 - PubMed
  125. Chem Biol Drug Des. 2010 Aug;76(2):130-41 - PubMed
  126. Mol Divers. 2003;6(3-4):297-313 - PubMed
  127. ACS Comb Sci. 2012 Mar 12;14(3):160-3 - PubMed
  128. J Med Chem. 1992 May 15;35(10):1887-97 - PubMed
  129. Mol Divers. 2005;9(1-3):171-86 - PubMed
  130. Bioorg Med Chem Lett. 2000 Jun 5;10(11):1159-62 - PubMed
  131. J Comb Chem. 2009 Nov-Dec;11(6):1078-82 - PubMed
  132. J Med Chem. 2010 Sep 23;53(18):6525-38 - PubMed
  133. J Org Chem. 2002 Apr 5;67(7):2093-100 - PubMed
  134. Bioorg Med Chem Lett. 2004 Oct 18;14(20):5219-22 - PubMed
  135. Org Lett. 2001 Mar 22;3(6):877-80 - PubMed
  136. Tetrahedron Lett. 2012 Apr 11;53(15):1998-2000 - PubMed
  137. Bioorg Med Chem. 2003 Jun 12;11(12):2551-68 - PubMed
  138. J Org Chem. 2007 Nov 9;72(23):8980-3 - PubMed
  139. Mol Divers. 2010 Aug;14(3):425-42 - PubMed
  140. ACS Comb Sci. 2012 May 14;14(5):309-15 - PubMed
  141. Eur J Pharmacol. 1997 Mar 19;322(2-3):243-7 - PubMed
  142. J Med Chem. 2006 Dec 28;49(26):7697-710 - PubMed
  143. Bioconjug Chem. 2012 Jul 18;23(7):1387-95 - PubMed
  144. J Org Chem. 2005 Jun 10;70(12):4735-40 - PubMed
  145. Chemistry. 2010 May 17;16(19):5528-37 - PubMed
  146. J Comb Chem. 2010 Jan-Feb;12(1):206-14 - PubMed
  147. Angew Chem Int Ed Engl. 1999 Aug;38(15):2096-2152 - PubMed
  148. Org Biomol Chem. 2008 May 21;6(10):1787-95 - PubMed
  149. Bioorg Med Chem Lett. 2005 Jun 15;15(12):3086-90 - PubMed
  150. Angew Chem Int Ed Engl. 2007;46(48):9312-5 - PubMed
  151. Org Biomol Chem. 2005 Jan 7;3(1):97-106 - PubMed
  152. Chem Commun (Camb). 2011 Jul 21;47(27):7845-7 - PubMed
  153. Mol Divers. 2012 Aug;16(3):601-6 - PubMed
  154. Org Lett. 2001 Dec 13;3(25):4079-82 - PubMed
  155. Bioorg Med Chem Lett. 2005 May 16;15(10):2579-82 - PubMed
  156. J Med Chem. 2005 Nov 3;48(22):6956-69 - PubMed
  157. J Org Chem. 2006 Jun 9;71(12):4578-84 - PubMed
  158. Org Biomol Chem. 2012 Dec 7;10(45):9004-12 - PubMed
  159. Bioorg Med Chem Lett. 2011 Mar 15;21(6):1823-6 - PubMed
  160. Angew Chem Int Ed Engl. 2002 Oct 18;41(20):3767-74 - PubMed
  161. J Comb Chem. 2002 Nov-Dec;4(6):584-90 - PubMed
  162. J Org Chem. 2008 Feb 15;73(4):1608-11 - PubMed
  163. Org Biomol Chem. 2010 Dec 7;8(23):5442-7 - PubMed
  164. J Org Chem. 2001 Oct 19;66(21):7044-50 - PubMed
  165. Arch Pharm (Weinheim). 2000 Aug;333(8):243-53 - PubMed

Publication Types